A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Babies
Status:
Completed
Trial end date:
2001-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if giving the anti-HIV drug nevirapine (NVP) to
HIV-positive pregnant women and their babies can help reduce the chance that a mother will
give HIV to her baby during delivery.
Previous studies suggest that NVP is a promising medication for blocking HIV transmission
from HIV-positive mothers to their babies.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)